Table 3.
Univariate and multivariate cox regression analysis of mortality risk factors for patients with COVID-19.
| Univariate |
Multivariate |
|||
|---|---|---|---|---|
| HR (95%CI) | P | HR (95%CI) | P | |
| Age | 7.434 (3.817–14.478) | <0.001 | 3.450 (1.627–7.314) | 0.001 |
| Gender | 0.515 (0.293–0.907) | 0.021 | 0.074 | |
| Hypertension | 1.926 (1.118–3.319) | 0.018 | 0.533 | |
| Coronary heart disease | 4.546 (2.563–8.065) | <0.001 | 1.855 (1.006–3.421) | 0.048 |
| cTnI-ultra | 3.479 (1.883–6.427) | <0.001 | 3.083 (1.616–5.883) | 0.001 |
| CK-MB | 6.292 (2.802–14.126) | <0.001 | 2.907 (1.233–6.854) | 0.015 |
| MYO | 3.225 (1.818–5.719) | <0.001 | 0.069 | |
| NT-proBNP | 6.326 (2.508–15.954) | <0.001 | 5.776 (2.272–14.682) | <0.001 |
| Cr | 2.723 (1.572–4.717) | 0.120 | 0.081 | |
Abbreviation: cTnI-ultra, cardiac troponin I-ultra; CK-MB, creatinine kinase–myocardial band; MYO, myoglobin; NT-proBNP, N-terminal pro-B-type natriuretic peptide; Cr, creatinine; HR, hazard ratio; CI, confidence interval.